GlassScriptPhysician profile
Shannon Jackson
NPI 1134616584
$1,353.56
in general payments reported to CMS, 2019-2025
28 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $383 · 2024: $489 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $125.77 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Merck Sharp & Dohme LLC | $123.02 | 2023-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Lilly USA, LLC | $77.89 | 2023-2024 | Jardiance, Zepbound, Mounjaro |
| Corium, LLC | $70.20 | 2023-2025 | Azstarys |
| Novo Nordisk INC | $62.55 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $61.22 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.00 | 2023-2024 | Caplyta |
| Ironshore Pharmaceuticals INC. | $57.93 | 2023-2024 | Jornay Pm |
| Amgen INC. | $57.59 | 2023-2024 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.27 | 2024-2025 | Jardiance, Synjardy |
| Exact Sciences Corporation | $54.51 | 2023 | Cologuard Collection Kit |
| Integra Lifesciences Corporation | $52.86 | 2024-2025 | Acclarent Aera, Relieva Spinplus Nav, Trudi Probe |
| Karl Storz Endoscopy-America | $50.46 | 2024 | Tele Pack |
| Astrazeneca Pharmaceuticals LP | $44.96 | 2023-2024 | Farxiga |
| Abbott Laboratories | $43.15 | 2024-2025 | Freestyle Libre 3 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.94 | 2023 | |
| Aerin Medical INC. | $39.91 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $39.00 | 2023 | Rexulti |
| Collegium Pharmaceutical, INC. | $36.92 | 2025 | Jornay Pm |
| Dexcom, INC. | $34.88 | 2024-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $33.41 | 2024 | Propel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.41 | 2024-2025 | Xifaxan |
| Advanced Bionics, LLC | $18.29 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Mylan Specialty L.P. | $18.18 | 2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $15.94 | 2024 | Dupixent |
| Neurocrine Biosciences, INC. | $15.88 | 2025 | |
| Axsome Therapeutics, INC. | $14.83 | 2023 | Auvelity |
| Lundbeck LLC | $14.59 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.